| 000 | 01099 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513203207.0 | ||
| 264 | 0 | _c20000307 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a1527-9995 | ||
| 024 | 7 |
_a10.1016/s0090-4295(99)00366-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarducci, M A | |
| 245 | 0 | 0 |
_aAdjuvant chemotherapy for T3 prostate cancer: not ready for prime time. _h[electronic resource] |
| 260 |
_bUrology _cFeb 2000 |
||
| 300 |
_a157-60 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 | _aProstatectomy |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 773 | 0 |
_tUrology _gvol. 55 _gno. 2 _gp. 157-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-4295(99)00366-0 _zAvailable from publisher's website |
| 999 |
_c10642304 _d10642304 |
||